Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech
London (ots/PRNewswire) - Bryan, Garnier & Co, the pan-European investment bank for growth companies, announces the successful $275 million Nasdaq IPO for Galapagos NV, a major European clinical-stage biotechnology company. Bryan, Garnier & Co is the only European investment bank in the IPO syndicate. The Galapagos ...
plus